AZD5851

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD5851, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma [Phase 1, Phase 2]